FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4556111000001101: Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21316301000001118 Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21316401000001114 Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Is pack of Neostigmine methylsulfate 2.5mg/1mL injection false Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has active ingredient Neostigmine methylsulfate false Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has VMP Neostigmine methylsulfate 2.5mg/1mL injection false Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has specific active ingredient Neostigmine methylsulfate true Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has VMP Neostigmine 2.5mg/1ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Has VMP Neostigmine 2.5mg/1ml solution for injection ampoules true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Neostigmine 2.5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules Is a True Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules Is a True Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Inferred relationship Existential restriction modifier
Neostigmine 2.5mg/1ml solution for injection ampoules (hameln pharma Ltd) 10 ampoule Is a True Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start